/term/is-credit-losses-provision/OSTO:ANNX Annexin Pharmaceuticals AB (OSTO:ANNX) Credit Losses Provis
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Credit Losses Provision

Annexin Pharmaceuticals AB (OSTO:ANNX) Credit Losses Provision


View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Credit Losses Provision?

Credit Losses Provision only applies to banks.

Annexin Pharmaceuticals AB (OSTO:ANNX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Credit Losses Provision
Comparable Companies
OSTO:BIOSGN XSAT:RESP NGM:COEGIN XSAT:ABERA OSTO:COMBI OSTO:EXPRS2 OSTO:SCOL OSTO:LPGO XSAT:DEX XSAT:CHOSA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Norrtullsgatan 6, Stockholm, SWE, SE-113 29
Website
https://www.annexinpharma.com
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.